Snowden Capital Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$956K Buy
2,053
+199
+11% +$83.7K 0.02% 594
2026
Q1
$700K Sell
1,854
-890
-32% -$381K 0.02% 657
2025
Q4
$1.17M Sell
2,744
-110
-4% -$47.9K 0.03% 479
2025
Q3
$1.28M Buy
2,854
+1,814
+174% +$822K 0.03% 450
2025
Q2
$506K Sell
1,040
-22
-2% -$12.5K 0.02% 759
2025
Q1
$653K Sell
1,062
-43
-4% -$24.4K 0.02% 635
2024
Q4
$585K Buy
1,105
+164
+17% +$92.5K 0.02% 706
2024
Q3
$566K Buy
941
+19
+2% +$10.8K 0.02% 715
2024
Q2
$500K Buy
922
+9
+1% +$5.16K 0.01% 751
2024
Q1
$586K Sell
913
-20
-2% -$12.2K 0.02% 693
2023
Q4
$546K Buy
933
+6
+0.6% +$3.36K 0.02% 662
2023
Q3
$482K Sell
927
-55
-6% -$28.6K 0.02% 674
2023
Q2
$532K Sell
982
-156
-14% -$85.3K 0.02% 704
2023
Q1
$612K Sell
1,138
-225
-17% -$115K 0.02% 637
2022
Q4
$696K Buy
1,363
+80
+6% +$38.9K 0.03% 565
2022
Q3
$560K Buy
1,283
+226
+21% +$109K 0.03% 604
2022
Q2
$496K Buy
+1,057
New +$516K 0.02% 635
2021
Q4
Sell
-717
Closed -$333K 2056
2021
Q3
$333K Buy
717
+39
+6% +$18.4K 0.02% 653
2021
Q2
$322K Buy
+678
New +$326K 0.02% 688

Other funds holding CHE

Snowden Capital Advisors's CHE Position: Q2 2026 in Review

Snowden Capital Advisors increased its Chemed (CHE) stake by 11% in Q2 2026, buying an estimated $83.7K and bringing the position to 2,053 shares worth $956K. The position accounts for 0.02% of the portfolio, ranked #594.

Snowden Capital Advisors first reported a position in CHE in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.28M in Q3 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Snowden Capital Advisors held 2,053 shares of Chemed worth $956K as of Q2 2026.
  • Snowden Capital Advisors bought 199 Chemed shares in Q2 2026, an estimated $83.7K.
  • Chemed made up 0.02% of Snowden Capital Advisors's portfolio in Q2 2026, its #594 holding.
  • Snowden Capital Advisors first reported a position in Chemed in Q2 2021 and has held it in 19 quarters since.
  • Snowden Capital Advisors's Chemed position peaked at $1.28M in Q3 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.